Radiopharmaceuticals for Lymphoscintigraphy: Including dusimetry and radiation considerations

https://doi.org/10.1016/S0001-2998(00)80059-8Get rights and content

The recognition of the importance of lymphoscintigraphy for identification of the sentinel lymph nodes in melanoma and breast cancer plays a significant role in the clinical management of these patients. The widespead clinical acceptance of this technique and the lack of an agreement on which radiopharmaceutical agent has the most ideal properties has resulted in a wide variety of agents being used clinically with other agents under investigation or development. This article reviews some of the physical properties that a radiopharmaceutical agent should possess and discusses in depth commonly used agents and lists some agents under development. This article also discusses the dosimetry and biological effects various radiophar-maceutical agents have for lymphoscintigraphy in melanoma and breast cancer patients. In view of the lack of a consensus agreement on which radiopharmaceutical agent will provide the optimal clincal information this article will provide an overview of potentially useful radiopharmaceutical agents and radiation dosimetry considerations.

References (41)

  • MeyerCM et al.

    Technetium-99m sulfur-colloid cutaneous lymphoscintigraphy in the management of truncal melanoma

    Radiology

    (1979)
  • LarsonSM et al.

    Radiopharmacology of a simplified technetium-99m-colloid preparation for photoscanning

    J Nucl Med

    (1966)
  • SteigmanJ et al.

    Technetium (VII) Compounds

  • Amersham Cygne

    Amersham Product Information: Solco NANOCOLL

    (1996)
  • WilhelmAJ et al.

    Radiopharmaceuticals in sentinel lymph-node detection-an overview

    Eur J Nucl Med

    (1999)
  • Amersham Cygne

    Amersham Product Information: ALBU-Res

    (1996)
  • SadekS et al.

    Preparation and evaluation of Tc-99m hydroxyethyl starch as a potential radiopharmaceutical for lymphoscintigraphy: Comparison with Tc-99m human serum albumin, Tc-99m dextran, and Tc-99m sulfur microcolloid

    Lymphology

    (1989)
  • PaganelliG et al.

    Optimized sentinel node scintigraphy in breast cancer

    Q J Nucl Med

    (1998)
  • PijpersR et al.

    Sentinel node identification with Tc-99m colloidal albumin lymphoscintigraphy and gamma probe guidance in breast cancer

    J Nucl Med

    (1996)
  • EshimaD et al.

    Technetium-99m-sulfur colloid for lymphoscintigraphy: Effects of preparation parameters

    J Nucl Med

    (1996)
  • Cited by (85)

    • Sentinel Lymph Node Identification in Patients With Breast Cancer Using Lymphosonography

      2023, Ultrasound in Medicine and Biology
      Citation Excerpt :

      Accurate assessment of potential LN involvement is essential to limit the removal to only the affected LNs as a way to minimize the anatomical disruption caused by an extensive axillary LN removal, which can result in lymphedema, nerve injury, shoulder dysfunction and other complications that may compromise functionality and quality of life (Lyman et al. 2005; Jang et al. 2022). Currently, the lymphatic system is mapped after the injection of blue dye and/or a radioactive tracer followed by a surgical excision (Hill et al. 1999; Eshima et al. 2000; Veronesi et al. 2003; Emerson et al. 2012). This approach has several limitations.

    • Preliminary evaluation of the potential of <sup>99m</sup>Tc carbonyl-DTPA-Rituximab as a tracer for sentinel lymph node detection

      2016, Applied Radiation and Isotopes
      Citation Excerpt :

      It should allow for scintigraphic imaging prior to surgery for preliminary localization and subsequent precise in situ detection using a hand-held gamma probe. 99mTc-labeled sulfur colloid and human serum albumin (HSA) nanocolloid are the prominent clinically employed radiotracers for SLN detection (Wilhelm et al., 1999; Eshima et al., 2000). These conventional nanoparticulate tracers are retained upon phagocytosis by the macrophages in the lymph node.

    • Radiopharmaceuticals for sentinel lymph node identification in breast cancer

      2023, Journal of Radioanalytical and Nuclear Chemistry
    View all citing articles on Scopus
    View full text